Anti-natrium/Iodide Symporter Antibodies and Other Anti-thyroid Antibodies in Children with Turner’s Syndrome

  • Anna M. Kucharska
  • Barbara Czarnocka
  • Urszula Demkow
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 756)


Antibodies against the Na/I symporter (anti-NIS ab) have been found in adult patients with autoimmune thyroid diseases. As easily available for the immune system, NIS can play a role in the initial stage of autoimmune thyroid diseases. Children with Turner’s syndrome (TS) being at high risk of autoimmune thyroid disease development seem a valuable group for the investigation of the early autoimmune process. The aim of the study was to investigate the presence of anti-NIS ab and its potential clinical significance in TS children. Fifty four girls with TS were examined (age 11.9 ± 2.46 years), and 23 healthy girls with normal thyroid function, free of autoimmune diseases. Anti-NIS antibodies were measured by the in-house ELISA method and the Western blotting. Sera considered positive for anti-NIS ab were used for the iodide uptake bioassay using COS7 cells stably transfected with hNIS. In all patients the thyroid function, antithyroid antibodies presence and thyroid ultrasonography were evaluated. In 20% of the patients a subclinical hypothyroidism was diagnosed and 70.4% had antithyroid antibodies (anti-TPO – 64.8% and Anti-Tg – 24%). Anti-NISab were present in 14.8% girls with TS and in none of the control group. Their presence was unrelated to other antithyroid antibodies titre or patients’ age. A positive correlation between the anti-NIS ab presence and the hypothyroidism was found (p < 0.04). Anti-NIS ab-positive sera did not suppress iodine uptake. In conclusion, anti-NIS antibodies were present in 14.8% of children with TS and they were related to the presence of hypothyroidism.


Autoantibodies Autoimmune thyroiditis Children Na/I symporter Turner’s syndrome 



We wish to thank Prof. Nancy Carrasco of the Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York for the gift of the plasmid containing full length human NIS cDNA. The authors also thank Dr Cornelia Rinderle of the BRAHMS Diagnostica GmbH Henningsdorf in Berlin for the evaluation of iodide uptake in bioassay.

Conflicts of interest: The authors declare no conflicts of interest in relation to this article.


  1. Ajjan, R. A., Findlay, C., Metcalfe, R. A., Watson, P. F., Crisp, M., Ludgaten, M., & Weetman, A. P. (1998). The modulation of the human sodium iodide symporter activity by Graves’ disease sera. Journal of Clinical Endocrinology and Metabolism, 83, 1217–1221.PubMedCrossRefGoogle Scholar
  2. Ajjan, R. A., Kemp, E. H., Waterman, E. A., Watson, P. F., Endo, T., Onaya, T., & Weetman, A. P. (2000). Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 85, 2020–2027.PubMedCrossRefGoogle Scholar
  3. Chin, H. S., Chin, D. K., Morgenthaler, N. G., Vassart, G., & Costagliola, S. (2000). Rarity of anti-Na/I symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD). Journal of Clinical Endocrinology and Metabolism, 85, 3937–3940.PubMedCrossRefGoogle Scholar
  4. Chiovato, L., Larizza, D., Bendinelli, G., Tonacchera, M., Marino, M., Mammoli, C., Lorini, R., Severi, F., & Pinchera, A. (1996). Autoimmune hypothyroidism and hyperthyroidism in patients with Turner’s syndrome. European Journal of Endocrinology, 134, 568–575.PubMedCrossRefGoogle Scholar
  5. Dai, G., Levy, O., & Carrasco, N. (1996). Cloning and characterization of the thyroid iodide transporter. Nature, 379, 458–460.PubMedCrossRefGoogle Scholar
  6. Dohan, O., De la Vieja, A., Paroder, V., Riedel, C., Artani, M., Reed, M., Ginter, Ch. S., & Carrasco, N. (2003). The sodium/iodide symporter (NIS): Characterisation, regulation, and medical significance. Endocrine Reviews, 24, 48–77.PubMedCrossRefGoogle Scholar
  7. Elsheikh, M., Wass, J. A. H., & Conway, G. S. (2001). Autoimmune thyroid syndrome in women with Turner’s syndrome- the association with karyotype. Clinical Endocrinology, 55, 223–226.PubMedCrossRefGoogle Scholar
  8. Endo, T., Kaneshige, M., Nakazato, M., Kogai, T., Saito, T., & Onaya, T. (1996a). Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto’s thyroiditis possesses iodide transport inhibitory activity. Biochemical and Biophysical Research Communications, 228, 199–202.PubMedCrossRefGoogle Scholar
  9. Endo, T., Kogai, T., Nakazato, M., Saito, T., Kaneshige, M., & Onaya, T. (1996b). Autoantibody against Na/I symporter in the sera of patients with autoimmune thyroid disease. Biochemical and Biophysical Research Communications, 224, 92–95.PubMedCrossRefGoogle Scholar
  10. Germain, E. L., & Plotnick, L. P. (1986). Age-related anti-thyroid antibodies and thyroid abnormalities in Turner’s syndrome. Acta Paediatrica Scandinavica, 75, 750–755.PubMedCrossRefGoogle Scholar
  11. Gruñeiro de Papendieck, L., Iorkansky, S., Coco, R., Rivarola, M. A., & Bergada, C. (1987). High incidence of thyroid disturbances in 49 children with Turner’s syndrome. The Journal of Pediatrics, 111, 258–261.PubMedCrossRefGoogle Scholar
  12. Levy, O., Dai, G., Riedel, C. X., Ginter, C. S., Paul, E. M., Lebowitz, A. N., & Carrasco, N. (1997). Characterisation of the thyroid Na+/I symporter with an anti-COOH terminus antibody. Proceedings of the National Academy of Sciences of the United States of America, 94, 5568–5573.PubMedCrossRefGoogle Scholar
  13. Morris, J. C., Bergert, E. R., & Bryant, W. P. (1997). Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: Evidence for the iodide transporter as an autoantigen. Thyroid, 7, 527–534.PubMedCrossRefGoogle Scholar
  14. Radetti, G., Mazzanti, L., Paganini, C., Bernasconi, S., Russo, G., Rigon, F., & Cacciari, E. (1995). Frequency, clinical and laboratory features of thyroiditis in girls with Turner’s syndrome. Acta Paediatrica, 84, 909–912.PubMedCrossRefGoogle Scholar
  15. Radetti, G., Gottardi, E., Bona, G., Corrias, A., Salardi, S., Loche, S., & Study Group for Thyroid Diseases of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED). (2006). The natural history of euthyroid Hashimoto’s thyroiditis in children. The Journal of Pediatrics, 149, 827–832.PubMedCrossRefGoogle Scholar
  16. Raspe, E., Costagliola, S., Ruf, J., Mariotti, S., Dumont, J. E., & Ludgate, M. (1995). Identification of the thyroid Na/I cotransporter as a potential autoantigen in thyroid autoimmune disease. European Journal of Endocrinology, 132, 399–405.PubMedCrossRefGoogle Scholar
  17. Riesco-Eizaguirre, G., & Santisteban, P. (2006). A perspective view of sodium iodide symporter research and its clinical implications. European Journal of Endocrinology, 155, 495–512.PubMedCrossRefGoogle Scholar
  18. Saenger, P., Albertsson Wikland, K., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., Lippe, B., Pasquino, A. M., Ranke, M. B., Rosenfeld, R., & Silberbach, M. (2001). Recommendations for the diagnosis and management of Turner’s syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 3061–3069.PubMedCrossRefGoogle Scholar
  19. Seissler, J., Wagner, S., Schott, M., Lettmann, M., Feldkamp, J., Scherbaum, W. A., & Morgenthaler, N. G. (2000). Low frequency of autoantibodies to the human Na/I symporter in patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 85, 4630–4634.PubMedCrossRefGoogle Scholar
  20. Smanik, P. A., Liu, Q., Furminger, T. L., Ryu, K., Xing, S., Mazzaferri, E. L., & Jhiang, S. M. (1996). Cloning of the human sodium iodide symporter. Biochemical and Biophysical Research Communications, 226, 339–345.PubMedCrossRefGoogle Scholar
  21. Tonacchera, M., Agretti, P., Ceccarini, G., Lenza, R., Refetoff, S., Santini, F., Pinchera, A., Chiovato, L., & Vitti, P. (2001). Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. European Journal of Endocrinology, 144, 611–618.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Anna M. Kucharska
    • 1
  • Barbara Czarnocka
    • 2
  • Urszula Demkow
    • 3
  1. 1.Department of Paediatrics and EndocrinologyMedical University of WarsawWarsawPoland
  2. 2.Department of BiochemistryMedical Center of Postgraduate EducationWarsawPoland
  3. 3.Department of Laboratory Diagnostics and Clinical Immunology of the Developmental AgeMedical University of WarsawWarsawPoland

Personalised recommendations